The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Rotavirus Vaccine Market Research Report 2025
Synopsis
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
The global Human Rotavirus Vaccine market was valued at US$ 188 million in 2023 and is anticipated to reach US$ 237.1 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
This report aims to provide a comprehensive presentation of the global market for Human Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rotavirus Vaccine.
Report Scope
The Human Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Merck
GlaxoSmithKline
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segment by Application
Hospitals & Clinics
Academic And Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
The global Human Rotavirus Vaccine market was valued at US$ 188 million in 2023 and is anticipated to reach US$ 237.1 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
This report aims to provide a comprehensive presentation of the global market for Human Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rotavirus Vaccine.
Report Scope
The Human Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Merck
GlaxoSmithKline
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segment by Application
Hospitals & Clinics
Academic And Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Rotavirus Vaccine Market Overview
1.1 Product Overview and Scope of Human Rotavirus Vaccine
1.2 Human Rotavirus Vaccine Segment by Type
1.2.1 Global Human Rotavirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Human Rotavirus Vaccine Segment by Application
1.3.1 Global Human Rotavirus Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Academic And Research
1.3.4 Others
1.4 Global Human Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Rotavirus Vaccine Revenue 2019-2030
1.4.2 Global Human Rotavirus Vaccine Sales 2019-2030
1.4.3 Global Human Rotavirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Rotavirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Rotavirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Human Rotavirus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rotavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rotavirus Vaccine, Product Type & Application
2.7 Human Rotavirus Vaccine Market Competitive Situation and Trends
2.7.1 Human Rotavirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Rotavirus Vaccine Players Market Share by Revenue
2.7.3 Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rotavirus Vaccine Retrospective Market Scenario by Region
3.1 Global Human Rotavirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Rotavirus Vaccine Global Human Rotavirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Human Rotavirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Human Rotavirus Vaccine Sales by Region: 2025-2030
3.3 Global Human Rotavirus Vaccine Global Human Rotavirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Human Rotavirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Human Rotavirus Vaccine Revenue by Region: 2025-2030
3.4 North America Human Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Human Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Rotavirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Human Rotavirus Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Rotavirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Human Rotavirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Human Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Rotavirus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Rotavirus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Rotavirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Human Rotavirus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Rotavirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Rotavirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Human Rotavirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Human Rotavirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Human Rotavirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Human Rotavirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Human Rotavirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Human Rotavirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Human Rotavirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Human Rotavirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Rotavirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Human Rotavirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Human Rotavirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Human Rotavirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Human Rotavirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Human Rotavirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Human Rotavirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Human Rotavirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Human Rotavirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Human Rotavirus Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Human Rotavirus Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rotavirus Vaccine Industry Chain Analysis
7.2 Human Rotavirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rotavirus Vaccine Production Mode & Process
7.4 Human Rotavirus Vaccine Sales and Marketing
7.4.1 Human Rotavirus Vaccine Sales Channels
7.4.2 Human Rotavirus Vaccine Distributors
7.5 Human Rotavirus Vaccine Customers
8 Human Rotavirus Vaccine Market Dynamics
8.1 Human Rotavirus Vaccine Industry Trends
8.2 Human Rotavirus Vaccine Market Drivers
8.3 Human Rotavirus Vaccine Market Challenges
8.4 Human Rotavirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
